Back to company

SPECIFIC PHARMA A/S: Financial statements 2022

CVR: 33161395

SPECIFIC PHARMA A/S (CVR 33161395) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 123,270,000 and a net result of DKK 7,769,000 compared with DKK 14,799,000 the year before. That is a decrease of 11.7% compared with the year before. The profit margin was 6.3%. Equity amounted to DKK 85,488,000. The solvency ratio was 82.9%. The company had 23 employees in the financial year.

Revenue
123,270,000 kr.
Gross Profit
26,382,000 kr.
Profit/Loss
7,769,000 kr.
Equity
85,488,000 kr.
Total Assets
103,079,000 kr.
Employees
23

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022123.3 mio.26.4 mio.7.8 mio.85.5 mio.23
2021139.6 mio.32.5 mio.14.8 mio.88.8 mio.21
2020128.2 mio.27 mio.8.2 mio.80.2 mio.16
2019146.4 mio.25.3 mio.8.9 mio.78.6 mio.15
2018145.7 mio.29.7 mio.14.8 mio.69.7 mio.12

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on SPECIFIC PHARMA A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

About SPECIFIC PHARMA A/S

SPECIFIC PHARMA A/S is a Danish company of the type Aktieselskab based in København SV, founded in 2010. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Uffe Kåre Jensen. The company is owned by NOMECO A/S. The company has 24 employees. In 2026, the company reported revenue of DKK 157,797,000 and a net result of DKK 15,192,000 compared with DKK 29,239,000 the year before. Equity amounted to DKK 98,645,000.